LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $12.12 Average Price Target from Analysts

LifeStance Health Group, Inc. (NASDAQ:LFST) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are currently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $12.3750.

Several equities research analysts have recently weighed in on the company. Zacks Research cut LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 13th. The Goldman Sachs Group initiated coverage on LifeStance Health Group in a research note on Friday, June 5th. They issued a “neutral” rating and a $9.00 price objective on the stock. Weiss Ratings upgraded LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 11th. KeyCorp increased their target price on shares of LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Finally, Wall Street Zen upgraded shares of LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 15th.

Insider Activity

In other news, COO Lisa K. Miller sold 47,912 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.85, for a total transaction of $519,845.20. Following the completion of the sale, the chief operating officer directly owned 281,289 shares in the company, valued at $3,051,985.65. This represents a 14.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Robert Bessler sold 894,337 shares of the stock in a transaction on Friday, June 26th. The stock was sold at an average price of $10.13, for a total transaction of $9,059,633.81. Following the sale, the director owned 539,763 shares of the company’s stock, valued at approximately $5,467,799.19. This trade represents a 62.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 14,629,850 shares of company stock valued at $154,952,012. Company insiders own 3.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Assetmark Inc. lifted its stake in shares of LifeStance Health Group by 17.0% in the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after purchasing an additional 1,367 shares during the period. California State Teachers Retirement System grew its stake in LifeStance Health Group by 1.6% during the fourth quarter. California State Teachers Retirement System now owns 125,682 shares of the company’s stock worth $885,000 after purchasing an additional 1,966 shares during the period. Vident Advisory LLC grew its stake in LifeStance Health Group by 12.7% during the second quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock worth $112,000 after purchasing an additional 2,447 shares during the period. Xponance LLC increased its holdings in LifeStance Health Group by 26.4% in the fourth quarter. Xponance LLC now owns 13,144 shares of the company’s stock worth $93,000 after purchasing an additional 2,745 shares in the last quarter. Finally, Diversified Trust Co increased its holdings in LifeStance Health Group by 14.8% in the first quarter. Diversified Trust Co now owns 21,532 shares of the company’s stock worth $137,000 after purchasing an additional 2,770 shares in the last quarter. 85.50% of the stock is owned by institutional investors.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $12.47 on Friday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. LifeStance Health Group has a 52 week low of $4.77 and a 52 week high of $12.97. The firm has a market cap of $4.84 billion, a PE ratio of 95.93 and a beta of 1.14. The firm’s fifty day moving average is $10.84 and its 200-day moving average is $8.41.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The business had revenue of $435.35 million during the quarter, compared to the consensus estimate of $414.58 million. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.LifeStance Health Group’s quarterly revenue was up 26.1% on a year-over-year basis. During the same period in the prior year, the business posted ($0.01) earnings per share. Sell-side analysts predict that LifeStance Health Group will post 0.16 earnings per share for the current year.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.